MedTrace Logo

Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile Dysfunction

NCT04361305 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2020-04-24

No results posted yet for this study

Summary

Premature ejaculation (PE) is a common disease in the andrology clinic. Currently, the effectiveness and outcome differences of drug treatment still need to be studied and demonstrated. Premature ejaculation concurrent with erectile dysfunction (ED) is common in outpatient clinics. The preferred treatment plan for these patients still needs to be further studied and explored, and the difference in the efficacy of different treatment regiments remain to be evaluated.

Conditions

Interventions

DRUG

Dapoxetine

30 mg tablets 1 to 3 hours before sexual activity prn (as needed) not to be taken more than once every 24 hours for 8 weeks Tadalafil 5 mg tablets every day for 8 weeks

DRUG

Tadalafil

5 mg tablets every day for 8 weeks

DRUG

Tadalafil

5 mg tablets every day for 8 weeks

Sponsors & Collaborators

  • Yan-Ping Huang

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-03
Primary Completion
2021-01-11
Completion
2021-04-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04361305 on ClinicalTrials.gov